Australia invests $1.9B more towards COVID-19 vaccine rollout

Australia has outlined plans to deliver Australia's COVID-19 vaccination program this year. The plan includes the a...

February 3, 2021 | Wednesday | News
Novavax COVID-19 Vaccine demonstrates 89.3% efficacy in UK Phase 3 Trial

Novavax, Inc., a biotechnology company developing next-generation vaccines for serious infectious diseases, announced th...

February 2, 2021 | Tuesday | News
Japan's TMDU, Fujitsu to develop management system for viral infections

Tokyo Medical and Dental University (TMDU) and Fujitsu Limited are developing a system that reduces the burden on t...

February 3, 2021 | Wednesday | News
Australia reports no specific risk for Pfizer vaccine in elderly patients

On January 14, 2021 the Therapeutic Goods Administration (TGA) received reports of about 30 deaths in over 40,000 e...

February 2, 2021 | Tuesday | News
Moderna to supply 40M COVID-19 Vaccine doses to Korea

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, on Jan 31, 2021,&...

January 31, 2021 | Sunday | News
Singapore provides important clinical implications for COVID-19 management

Antibodies and T cells are components of the human immune system that directly act against viral infections and eliminat...

February 2, 2021 | Tuesday | News
Seegene develops world first COVID-19 variant test

South Korea's biotechnology firm Seegene has developed the world's first COVID-19 diagnostic variant test, capable ...

February 1, 2021 | Monday | News
CEPI Call provides up to $140 M in funding to vaccine developers

Norway based CEPI, the Coalition for Epidemic Preparedness Innovations, has opened a new funding opportunity to support ...

January 29, 2021 | Friday | News
South Korean medical AI firm to assist COVID-19 screening and diagnosis in Indonesia

Lunit, a South Korean medical AI software company, on Jan 27, 2021, announced a partnership with a leading PACS provider...

January 28, 2021 | Thursday | News
Japan supports precision prediction model for COVID-19 outcomes

BC Platforms, a global leader in clinical and genomic data management, analytics and access, has announced that it has j...

January 28, 2021 | Thursday | News
GI-Cell, IVI ink MOU to develop next-generation COVID-19 vaccine

GI-Cell, an affiliate of GI-Innovation, a biotechnology company for cell therapy development, signed a memor...

January 27, 2021 | Wednesday | News
Malaysia secures 18.4 M doses of Sputnik V and Sinovac vaccines

Health ministry in Malaysia has inked agreements to purchase Russian Gamaleya's Sputnik V vaccine (18.4 M doses) an...

January 28, 2021 | Thursday | News
Bioalpha strengthens COVID-19 vaccine distribution in Malaysia

Bioalpha International Sdn Bhd (BISB), a wholly-owned subsidiary of Bioalpha, has entered into a Procurement and Di...

January 27, 2021 | Wednesday | News
Medigen Vaccine Biologics initiates Ph 2 trial of COVID-19 vaccine in Taiwan

Medigen Vaccine Biologics Corporation (MVC), a biopharmaceutical company focusing on the development and production of v...

January 29, 2021 | Friday | News
COMIRNATY becomes first COVID-19 vaccine to receive EUA in Hong Kong

BioNTech SE and Shanghai Fosun Pharmaceutical (Group) Co., Ltd. have announced that according to the Food...

January 27, 2021 | Wednesday | News
Australia provisionally approves Pfizer COVID-19 vaccine

The Therapeutic Goods Administration (TGA) has provisionally approved the Pfizer/BioNTech COVID-19 vaccine for use in Au...

January 25, 2021 | Monday | News
COVAX announces new agreement, plans for initial doses of vaccine deliveries

COVAX, the global initiative to ensure rapid and equitable access to COVID-19 vaccines for all countries, regardle...

January 25, 2021 | Monday | News
New Zealand develops early warning indicator for viral infection

Datamine, a New Zealand based AI company, has created ëlarm: a personal early warning indicator for viral...

January 25, 2021 | Monday | News